EU regulators approve the use of Moderna’s COVID-19 vaccine in teens

European drug regulators on Friday recommend approving the use of Moderna’s COVID-19 vaccine between the ages of 12 and 17, the way it will be a safe second shot for use in adolescent blocks. Opened.

According to the European Medicines Agency (EMA), the use of the Spikevax branded vaccine is the same for adolescents and people over the age of 18, with the addition of the vaccine producing an antibody response similar to that seen at ages 18-25. It is said that it was obtained. ..

Vaccination of children has been considered important for reaching herd immunity against the new coronavirus and in the light of the highly contagious delta mutants. Moderna in May said the vaccine turned out to be safe and effective in teens.

The EMA Safety Commission found that the common side effects of teenagers after vaccination were similar to those seen in the elderly due to the small study size, but the study detected new and unusual side effects. It was not possible to estimate the risk of known side effects such as myocarditis or pericarditis. ..

Pushkara Aripaka